SM
ZYME icon

SG3 Management’s Zymeworks ZYME Stock Holding History

SG3 Management’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-37,500
Closed -$615K – 1419
2021
Q4 		$615K Buy
37,500
+24,500
+188% +$511K 0.01% 587
2021
Q3 		$378K Buy
+13,000
New +$432K 0.01% 654
2020
Q4 		– Sell
-180,000
Closed -$8.38M – 1253
2020
Q3 		$8.38M Buy
+180,000
New +$6.18M 0.31% 75

Other funds holding ZYME

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

SG3 Management's ZYME Position: Q4 2021 in Review

SG3 Management sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 6,100 shares — an estimated $127K sold.

SG3 Management first reported a position in ZYME in Q3 2021 and held it in 1 quarter. The position peaked at $177K in Q3 2021. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

  • SG3 Management reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
  • SG3 Management sold 6,100 Zymeworks shares in Q4 2021, an estimated $127K.
  • SG3 Management first reported a position in Zymeworks in Q3 2021 and held it in 1 quarter.
  • SG3 Management's Zymeworks position peaked at $177K in Q3 2021.
  • 114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.